These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

118 related items for PubMed ID: 12376150

  • 1. SR-141716A-induced stimulation of locomotor activity. A structure-activity relationship study.
    Bass CE, Griffin G, Grier M, Mahadevan A, Razdan RK, Martin BR.
    Pharmacol Biochem Behav; 2002 Dec; 74(1):31-40. PubMed ID: 12376150
    [Abstract] [Full Text] [Related]

  • 2. Reversal of SR 141716A-induced head-twitch and ear-scratch responses in mice by delta 9-THC and other cannabinoids.
    Janoyan JJ, Crim JL, Darmani NA.
    Pharmacol Biochem Behav; 2002 Dec; 71(1-2):155-62. PubMed ID: 11812518
    [Abstract] [Full Text] [Related]

  • 3. Delta(9)-tetrahydrocannabinol and synthetic cannabinoids prevent emesis produced by the cannabinoid CB(1) receptor antagonist/inverse agonist SR 141716A.
    Darmani NA.
    Neuropsychopharmacology; 2001 Feb; 24(2):198-203. PubMed ID: 11120402
    [Abstract] [Full Text] [Related]

  • 4. 3-Substituted pyrazole analogs of the cannabinoid type 1 (CB₁) receptor antagonist rimonabant: cannabinoid agonist-like effects in mice via non-CB₁, non-CB₂ mechanism.
    Wiley JL, Selley DE, Wang P, Kottani R, Gadthula S, Mahadeven A.
    J Pharmacol Exp Ther; 2012 Feb; 340(2):433-44. PubMed ID: 22085649
    [Abstract] [Full Text] [Related]

  • 5. Cannabinoid CB(1) receptor expression, activation and detection of endogenous ligand in trabecular meshwork and ciliary process tissues.
    Stamer WD, Golightly SF, Hosohata Y, Ryan EP, Porter AC, Varga E, Noecker RJ, Felder CC, Yamamura HI.
    Eur J Pharmacol; 2001 Nov 23; 431(3):277-86. PubMed ID: 11730719
    [Abstract] [Full Text] [Related]

  • 6. SR 141716A, a CB1 cannabinoid receptor antagonist, potentiates the locomotor stimulant effects of amphetamine and apomorphine.
    Masserano JM, Karoum F, Wyatt RJ.
    Behav Pharmacol; 1999 Jul 23; 10(4):429-32. PubMed ID: 10780811
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Analogs of SR-141716A (Rimonabant) alter d-amphetamine-evoked [3H] dopamine overflow from preloaded striatal slices and amphetamine-induced hyperactivity.
    Miller DK, Rodvelt KR, Constales C, Putnam WC.
    Life Sci; 2007 Jun 13; 81(1):63-71. PubMed ID: 17532007
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Precipitated cannabinoid withdrawal is reversed by Delta(9)-tetrahydrocannabinol or clonidine.
    Lichtman AH, Fisher J, Martin BR.
    Pharmacol Biochem Behav; 2001 Jun 13; 69(1-2):181-8. PubMed ID: 11420084
    [Abstract] [Full Text] [Related]

  • 14. Effects of cannabinoid receptor ligands on psychosis-relevant behavior models in the rat.
    Martin RS, Secchi RL, Sung E, Lemaire M, Bonhaus DW, Hedley LR, Lowe DA.
    Psychopharmacology (Berl); 2003 Jan 13; 165(2):128-35. PubMed ID: 12404071
    [Abstract] [Full Text] [Related]

  • 15. Synthesis and characterization of NESS 0327: a novel putative antagonist of the CB1 cannabinoid receptor.
    Ruiu S, Pinna GA, Marchese G, Mussinu JM, Saba P, Tambaro S, Casti P, Vargiu R, Pani L.
    J Pharmacol Exp Ther; 2003 Jul 13; 306(1):363-70. PubMed ID: 12663689
    [Abstract] [Full Text] [Related]

  • 16. WIN-55,212-2 and SR-141716A alter nicotine-induced changes in locomotor activity, but do not alter nicotine-evoked [3H]dopamine release.
    Rodvelt KR, Bumgarner DM, Putnam WC, Miller DK.
    Life Sci; 2007 Jan 02; 80(4):337-44. PubMed ID: 17067637
    [Abstract] [Full Text] [Related]

  • 17. Involvement of other neurotransmitters in behaviors induced by the cannabinoid CB1 receptor antagonist SR 141716A in naive mice.
    Darmani NA, Pandya DK.
    J Neural Transm (Vienna); 2000 Jan 02; 107(8-9):931-45. PubMed ID: 11041273
    [Abstract] [Full Text] [Related]

  • 18. Acute administration of the CB1 cannabinoid receptor antagonist SR 141716A induces anxiety-like responses in the rat.
    Navarro M, Hernández E, Muñoz RM, del Arco I, Villanúa MA, Carrera MR, Rodríguez de Fonseca F.
    Neuroreport; 1997 Jan 20; 8(2):491-6. PubMed ID: 9080435
    [Abstract] [Full Text] [Related]

  • 19. Cannabinoid CB(1) antagonist SR 141716A attenuates reinstatement of heroin self-administration in heroin-abstinent rats.
    Fattore L, Spano S, Cossu G, Deiana S, Fadda P, Fratta W.
    Neuropharmacology; 2005 Jun 20; 48(8):1097-104. PubMed ID: 15910886
    [Abstract] [Full Text] [Related]

  • 20. SR 141716A, a cannabinoid receptor antagonist, reverses the behavioural effects of anandamide-treated rats.
    Costa B, Vailati S, Colleoni M.
    Behav Pharmacol; 1999 May 20; 10(3):327-31. PubMed ID: 10780247
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.